Travere Therapeutics Target Price

See Travere Therapeutics's analyst price targets ($70) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$67.51

Average Target Price

$70.00

3.7% upside

4 analysts in the last 4 months

High: $78 | Low: $65

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-10	Evercore ISI	$78	15.5% upside
2026-08-06	Canaccord Genuity	$70	3.7% upside
2026-06-25	GuggenheimVamil Divan	$65	3.7% downside
2026-06-02	H.C. WainwrightJoseph Pantginis	$67	0.8% downside
2026-04-14	Piper Sandler	$49	27.4% downside
2026-04-14	Guggenheim	$54	20% downside
2026-01-14	GuggenheimVamil Divan	$49	27.4% downside
2025-09-10	JefferiesMaury Raycroft	$35	48.2% downside
2024-10-31	Evercore ISILiisa Bayko	$33	51.1% downside
2024-10-21	Wells FargoMohit Bansal	$27	60% downside
2024-10-10	Evercore ISILiisa Bayko	$30	55.6% downside
2024-10-09	Bank of America SecuritiesJason Zemansky	$20	70.4% downside
2024-10-01	BarclaysCarter Gould	$18	73.3% downside
2024-09-27	GuggenheimVamil Divan	$23	65.9% downside
2024-09-27	H.C. WainwrightEd Arce	$18	73.3% downside
2024-09-27	Bank of America SecuritiesGreg Harrison	$18	73.3% downside
2024-09-10	Canaccord GenuityEd Nash	$23	65.9% downside
2024-09-09	GuggenheimVamil Divan	$12.5	81.5% downside
2024-08-28	Piper SandlerNicole Gabreski	$12	82.2% downside
2024-08-02	H.C. WainwrightEd Arce	$10	85.2% downside
2024-05-07	Canaccord GenuityEd Nash	$9	86.7% downside
2024-04-24	H.C. WainwrightEd Arce	$9.5	85.9% downside
2022-12-05	Wells Fargo	$28	58.5% downside

Travere Therapeutics (TVTX) FAQ

Travere Therapeutics posts a target price of $70. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $70 for TVTX means covering analysts, on average, see the stock 3.7% upside of $67.51 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for TVTX's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Travere Therapeutics's other metric pages and overview cover the third.

Judging Travere Therapeutics against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $70 here, then scan peer and history charts to see if the gap is persistent.